Correlation between Efficacy and Cardiovascular Adverse Events in Patients with Advanced Solid Cancer Who Received VEGF Pathway Inhibitors: Hypertension within the First Eight Weeks Is Associated with Favorable Outcomes of Patients Treated with VEGF Pathway InhibitorsYuya Yoshida, Chikashi Ishioka, Hideharu Yamada et al.|Internal Medicine|2024Cited by 4
Three cases of venous thromboembolism in advanced cancer patientsKeigo Komine, Chikashi Ishioka, Masanobu Takahashi et al.|Annals of Oncology|2018Cited by 0